PL3328361T3 - Cząstki nanożywicy zawierające lek - Google Patents
Cząstki nanożywicy zawierające lekInfo
- Publication number
- PL3328361T3 PL3328361T3 PL16829974T PL16829974T PL3328361T3 PL 3328361 T3 PL3328361 T3 PL 3328361T3 PL 16829974 T PL16829974 T PL 16829974T PL 16829974 T PL16829974 T PL 16829974T PL 3328361 T3 PL3328361 T3 PL 3328361T3
- Authority
- PL
- Poland
- Prior art keywords
- drug loaded
- nanoresin particles
- loaded nanoresin
- particles
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Ophthalmology & Optometry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2841MU2015 | 2015-07-27 | ||
PCT/IN2016/050253 WO2017017699A1 (en) | 2015-07-27 | 2016-07-27 | Drug loaded nanoresin particles |
EP16829974.1A EP3328361B1 (en) | 2015-07-27 | 2016-07-27 | Drug loaded nanoresin particles |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3328361T3 true PL3328361T3 (pl) | 2021-12-13 |
Family
ID=57884335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL16829974T PL3328361T3 (pl) | 2015-07-27 | 2016-07-27 | Cząstki nanożywicy zawierające lek |
Country Status (6)
Country | Link |
---|---|
US (2) | US20190008772A1 (pl) |
EP (2) | EP3328361B1 (pl) |
JP (2) | JP6856620B2 (pl) |
ES (1) | ES2891344T3 (pl) |
PL (1) | PL3328361T3 (pl) |
WO (1) | WO2017017699A1 (pl) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6856620B2 (ja) * | 2015-07-27 | 2021-04-07 | サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッドSun Pharma Advanced Research Company Limited | 薬剤搭載ナノ樹脂粒子 |
MX2021001276A (es) | 2018-07-31 | 2021-07-15 | Microbion Corp | Composiciones de bismuto-tiol y metodos para tratar heridas. |
FR3108841B1 (fr) * | 2020-04-06 | 2023-11-03 | Algotherapeutix | Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline |
EP4277660A1 (en) * | 2021-01-13 | 2023-11-22 | Sun Pharma Advanced Research Company Ltd | Method of reducing elevated intraocular pressure |
WO2023158787A1 (en) | 2022-02-17 | 2023-08-24 | Woolsey Pharmaceuticals, Inc. | Taste-masking oral formulations of fasudil |
WO2023158789A1 (en) | 2022-02-17 | 2023-08-24 | Woolsey Pharmaceuticals, Inc. | Oral formulations of fasudil with ion exchange resin |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA161597A (en) * | 1915-03-02 | 1915-03-30 | John R. Van Wormer | Box |
CA1161597A (en) | 1978-09-19 | 1984-01-31 | Rohm And Haas Company | Emulsion copolymer cation exchange resins and ion exchange process therewith |
US4380590A (en) | 1978-09-19 | 1983-04-19 | Rohm And Haas Company | Emulsion copolymer cation exchange resins |
GB9005498D0 (en) * | 1990-03-12 | 1990-05-09 | Beecham Group Plc | Composition |
US7001615B1 (en) * | 2001-12-07 | 2006-02-21 | Alcon, Inc. | Sustained release ophthalmic, otic and nasal suspension |
CN100548271C (zh) * | 2004-01-20 | 2009-10-14 | 阿勒根公司 | 用于眼部的局部治疗、并优选包括有曲安奈德及透明质酸的组合物 |
US8969415B2 (en) * | 2006-12-01 | 2015-03-03 | Allergan, Inc. | Intraocular drug delivery systems |
US20090098192A1 (en) * | 2007-10-11 | 2009-04-16 | Fuisz Richard C | Extrudable and Extruded Compositions for Delivery of Bioactive Agents, Method of Making Same and Method of Using Same |
EP2684801B1 (en) | 2008-08-05 | 2015-07-08 | MannKind Corporation | Powder dispensing and sensing apparatus and method of dispensing and sensing powder |
US9095506B2 (en) * | 2008-11-17 | 2015-08-04 | Allergan, Inc. | Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof |
US8142976B2 (en) * | 2009-12-03 | 2012-03-27 | Eastman Kodak Company | Method for preparing multiple emulsion and porous polymer particles therefrom |
US20130230587A1 (en) * | 2010-11-10 | 2013-09-05 | Rubicon Research Private Limited | Sustained release compositions |
JP5808214B2 (ja) * | 2011-09-30 | 2015-11-10 | 株式会社トクヤマ | 貼付剤 |
JP2017517550A (ja) * | 2014-06-13 | 2017-06-29 | ユナイテッド セラピューティクス コーポレイション | トレプロスチニル製剤 |
JP6567648B2 (ja) * | 2014-07-28 | 2019-08-28 | サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッドSun Pharma Advanced Research Company Limited | 薬物のバイオアベイラビリティーの増加および/または眼作用の持続方法 |
JP6856620B2 (ja) * | 2015-07-27 | 2021-04-07 | サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッドSun Pharma Advanced Research Company Limited | 薬剤搭載ナノ樹脂粒子 |
-
2016
- 2016-07-27 JP JP2018504264A patent/JP6856620B2/ja active Active
- 2016-07-27 WO PCT/IN2016/050253 patent/WO2017017699A1/en active Application Filing
- 2016-07-27 ES ES16829974T patent/ES2891344T3/es active Active
- 2016-07-27 US US15/747,032 patent/US20190008772A1/en not_active Abandoned
- 2016-07-27 EP EP16829974.1A patent/EP3328361B1/en active Active
- 2016-07-27 EP EP21195946.5A patent/EP3943072A1/en not_active Withdrawn
- 2016-07-27 PL PL16829974T patent/PL3328361T3/pl unknown
-
2019
- 2019-12-09 US US16/707,833 patent/US11559487B2/en active Active
-
2021
- 2021-03-18 JP JP2021044692A patent/JP7236484B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
US11559487B2 (en) | 2023-01-24 |
EP3328361A4 (en) | 2019-04-10 |
JP7236484B2 (ja) | 2023-03-09 |
WO2017017699A1 (en) | 2017-02-02 |
US20190008772A1 (en) | 2019-01-10 |
EP3943072A1 (en) | 2022-01-26 |
JP2021105009A (ja) | 2021-07-26 |
ES2891344T3 (es) | 2022-01-27 |
EP3328361B1 (en) | 2021-09-15 |
JP2018525370A (ja) | 2018-09-06 |
JP6856620B2 (ja) | 2021-04-07 |
EP3328361A1 (en) | 2018-06-06 |
US20200170951A1 (en) | 2020-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL270954A (en) | Pharmaceutical compounds | |
IL258213B (en) | Pharmaceutical compounds | |
GB201414730D0 (en) | Pharmaceutical compound | |
GB201506658D0 (en) | Pharmaceutical compounds | |
GB201504675D0 (en) | Pharmaceutical compounds | |
IL258246A (en) | Pharmaceutical compounds | |
GB201404922D0 (en) | Pharmaceutical compounds | |
GB201506660D0 (en) | Pharmaceutical compounds | |
GB201519352D0 (en) | Pharmaceutical compounds | |
GB201416513D0 (en) | Pharmaceutical compounds | |
PL3328361T3 (pl) | Cząstki nanożywicy zawierające lek | |
GB201506933D0 (en) | Pharmaceutical compounds | |
GB201502567D0 (en) | Pharmaceutical compounds | |
GB201417707D0 (en) | Pharmaceutical compounds | |
GB201402783D0 (en) | Powder delivery means | |
EP3217965C0 (en) | PHARMACEUTICAL PROCESS | |
IL250160A0 (en) | medicinal substance | |
ZA201708393B (en) | Large particles | |
GB201608923D0 (en) | Drug delivery particles | |
GB201517451D0 (en) | Pharmaceutical compounds | |
GB201503733D0 (en) | New drug application | |
GB201503731D0 (en) | New drug application | |
GB201508022D0 (en) | Pharmaceutical compounds | |
GB201416969D0 (en) | Pharmaceutical compounds | |
GB201416968D0 (en) | Pharmaceutical compounds |